ATEC Reports Q3 Revenue, Adjusts 2026 Outlook
Alphatec Holdings reported Q3 revenue of $221M; lowered fiscal 2026 revenue guidance to $862M due to lower biologics, while reporting strong surgical growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed